246 related articles for article (PubMed ID: 29689304)
1. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
3. Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model.
Liu X; Zhang M; Shao C; Sun H; Zhang B; Guo Z; Sun J; Qi F; Zhang Y; Niu H; Sun W
Mol Cell Proteomics; 2023 Aug; 22(8):100603. PubMed ID: 37348606
[TBL] [Abstract][Full Text] [Related]
4. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
[TBL] [Abstract][Full Text] [Related]
5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
6. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
[TBL] [Abstract][Full Text] [Related]
7. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
Jamal M; Taneja K; Arora S; Barod R; Rogers CG; Sanchez J; Gupta NS; Williamson SR
Int J Surg Pathol; 2018 Sep; 26(6):536-541. PubMed ID: 29560759
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.
Shah PH; Lyon TD; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Thompson RH
BJU Int; 2019 Feb; 123(2):270-276. PubMed ID: 30113768
[TBL] [Abstract][Full Text] [Related]
11. Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion.
Bonsib SM; Bhalodia A
Mod Pathol; 2011 Dec; 24(12):1578-85. PubMed ID: 21822202
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
Yang J; Li X; Tian MJ; Wang LN; Cheng TT; Chen W
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
[TBL] [Abstract][Full Text] [Related]
13. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
[TBL] [Abstract][Full Text] [Related]
14. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
[TBL] [Abstract][Full Text] [Related]
18. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
[TBL] [Abstract][Full Text] [Related]
19. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of the proteome, glycoproteome, and N-glycome of clear cell renal cell carcinoma plasma before and after curative nephrectomy.
Gbormittah FO; Lee LY; Taylor K; Hancock WS; Iliopoulos O
J Proteome Res; 2014 Nov; 13(11):4889-900. PubMed ID: 25184692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
